Asheville Rheumatology & Osteoporosis Research Asso P. A. — Asheville, North Carolina

Asheville Rheumatology & Osteoporosis Research Asso P. A. is a clinical research site located in Asheville, North Carolina, United States 28801.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Asheville Rheumatology & Osteoporosis Research Asso P. A. has participated in 2 clinical trials.

Therapeutic areas: Rheumatoid Arthritis (RA), Rheumatoid Arthritis.

Sponsors: Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Asheville

Browse all research sites in North Carolina · View every site in Asheville

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Asheville Rheumatology & Osteoporosis Research Asso P. A.?

Asheville Rheumatology & Osteoporosis Research Asso P. A. has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Asheville Rheumatology & Osteoporosis Research Asso P. A. conducted?

Asheville Rheumatology & Osteoporosis Research Asso P. A. has 2 clinical trials on record. Their work covers Rheumatoid Arthritis (RA), Rheumatoid Arthritis.

Is Asheville Rheumatology & Osteoporosis Research Asso P. A. accredited by Crixeo Clinical Trials?

Asheville Rheumatology & Osteoporosis Research Asso P. A. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Asheville Rheumatology & Osteoporosis Research Asso P. A.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.